Conversely, other studies suggests that PPIs do not impact overall survival and progression‐free survival in patients treated with PD‐1/PD‐L1 ICIs for non‐small cell lung cancer and advanced hepatocellular carcinoma.16, 17. The gene discussed is CD274; the disease is lung cancer.